These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8324301)
21. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Wilde MI; Benfield P Drugs; 1995 Mar; 49(3):411-39. PubMed ID: 7774514 [TBL] [Abstract][Full Text] [Related]
22. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM; Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688 [TBL] [Abstract][Full Text] [Related]
23. Clinical overview of serotonin reuptake inhibitors. Rickels K; Schweizer E J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922 [TBL] [Abstract][Full Text] [Related]
24. Introductory comments: a brief history of the development of paroxetine. Braestrup C Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():1-3. PubMed ID: 1431006 [TBL] [Abstract][Full Text] [Related]
28. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Benfield P; Heel RC; Lewis SP Drugs; 1986 Dec; 32(6):481-508. PubMed ID: 2878798 [TBL] [Abstract][Full Text] [Related]
29. Recent pharmacologic advances in antidepressant therapy for the elderly. Preskorn SH Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477 [TBL] [Abstract][Full Text] [Related]
31. Milnacipran. A review of its use in depression. Spencer CM; Wilde MI Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315 [TBL] [Abstract][Full Text] [Related]
32. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. Dick IE; Brochu RM; Purohit Y; Kaczorowski GJ; Martin WJ; Priest BT J Pain; 2007 Apr; 8(4):315-24. PubMed ID: 17175203 [TBL] [Abstract][Full Text] [Related]
33. Paroxetine: a pharmacological review. Johnson AM Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():15-24. PubMed ID: 1331230 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety. Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372 [TBL] [Abstract][Full Text] [Related]
35. Paroxetine: a review of clinical experience. Dunner D; Kumar R Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236 [TBL] [Abstract][Full Text] [Related]
36. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. Dorman T Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():53-8. PubMed ID: 1431012 [TBL] [Abstract][Full Text] [Related]
37. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. DeVane CL J Clin Psychiatry; 2003; 64 Suppl 18():14-9. PubMed ID: 14700450 [TBL] [Abstract][Full Text] [Related]
38. Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy. Dunbar GC Pharmacology; 1995 Sep; 51(3):137-44. PubMed ID: 7501698 [TBL] [Abstract][Full Text] [Related]
39. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. Gottlieb SS; Kop WJ; Thomas SA; Katzen S; Vesely MR; Greenberg N; Marshall J; Cines M; Minshall S Am Heart J; 2007 May; 153(5):868-73. PubMed ID: 17452166 [TBL] [Abstract][Full Text] [Related]